NCT02122575View on ClinicalTrials.gov

Effect of Fasting on the NLRP3 Inflammasome

CompletedOBSERVATIONAL
Enrollment

23

Participants

Timeline

Start Date

April 21, 2014

Primary Completion Date

March 6, 2017

Study Completion Date

January 27, 2021

Conditions
Cardiovascular DiseaseInflammatory Disease
Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT02122575 - Effect of Fasting on the NLRP3 Inflammasome | Biotech Hunter | Biotech Hunter